Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;19(3):343-355.
doi: 10.1016/j.sapharm.2022.11.004. Epub 2022 Nov 13.

Attitudes and beliefs regarding the use of herbs and supplementary medications with COVID-19: A systematic review

Affiliations

Attitudes and beliefs regarding the use of herbs and supplementary medications with COVID-19: A systematic review

Abderrezzaq Soltani et al. Res Social Adm Pharm. 2023 Mar.

Abstract

Background and aim: There is growing interest in using herbs and supplementary medications to treat and/or prevent COVID-19, evidenced by multiple reports exploring their effectiveness and safety. From a health psychology perspective, the desire to use herbs and supplementary medications to prevent and/or treat COVID-19 is a health behavior which is attributed to attitudes and beliefs. This systematic review critically appraised and synthesized the data from studies investigating these attitudes and beliefs.

Methods: EMBASE, PubMed, ScienceDirect, Scopus, Cochrane (library), and WebOfScience were searched from inception to December 13, 2021 for studies investigating attitudes and beliefs on the use of herbs and supplementary medications to treat and/or prevent COVID-19.

Results: A total of 17 articles were identified for inclusion. All except one were of cross-sectional design. Participants across most studies had a positive attitude towards using herbs and supplementary medications. They believed that herbs and supplementary medications were effective and were confident in their value in preventing and/or treating COVID-19 symptoms. The majority of included studies had significant flaws in study design and reporting, including inconsistent definitions of herbs and supplementary medications, a lack of theoretical models and conceptual frameworks underpinning the study of beliefs and attitudes, in addition to methodological issues of robustness affecting the validity and reliability of data.

Conclusion: The use of herbs and supplementary medicines to prevent and/or treat COVID-19 could well be driven by a positive attitude stemming from beliefs of effectiveness and safety. There is a need for well-designed studies on attitudes and beliefs that are driven by health behavior theories to permit generalizability of findings and establish more conclusive relationships between beliefs, attitudes and the decision to use herbs and supplementary medications to treat and/or prevent COVID-19.

Keywords: Attitudes; Beliefs; COVID-19; Herbs; Supplementary medications; Systematic review.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest All authors declare no conflict of interests.

Figures

Fig. 1
Fig. 1
Study Selection Process.

Similar articles

Cited by

References

    1. World Health organization Q&A on coronaviruses (COVID-19) 2020. https://www.who.int/news-room/questions-and-answers/item/coronavirus-dis... Published October 24.
    1. Zhang J., Xie B., Hashimoto K. Current status of potential therapeutic candidates for the COVID-19 crisis. Brain Behav Immun. 2020;87:59–73. - PMC - PubMed
    1. WHO Solidarity Trial Consortium Repurposed antiviral drugs for Covid-19—interim WHO solidarity trial results. N Engl J Med. 2021;384(6):497–511. - PMC - PubMed
    1. Martinez M.A. Clinical trials of repurposed antivirals for SARS-CoV-2. Antimicrob Agents Chemother. 2020;64(9):e01101–e01120. - PMC - PubMed
    1. National Center for Complementary and Integrative Health COVID-19 and “alternative” treatments: what you need to know. NCCIH. https://www.nccih.nih.gov/health/covid-19-and-alternative-treatments-wha... Published October 15, 2021.

Publication types